NeoStem (NBS +1.5%) holds in the green today after the company announced the geographic patent expansion of its lead product candidate, AMR-001, with the notice of a grant in Malaysia and notice of recommendation for allowance in the Philippines. These patents are in the family of US patent titled "Compositions and Methods of Vascular Injury Repair" and protected a chemotactic stem cell product enriched for CD34+ cells that treats injury from acute myocardial infarction.
NeoStem (NBS +1.5%) holds in the green today after the company announced the geographic patent...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs